Intralobar Pulmonary Sequestration and Increased Serum CA 19-9

  • Massimo Montalto Department of Internal Medicine, Gemelli Hospital, Catholic University, Rome
  • Michele Impagnatiello Department of Internal Medicine, Gemelli Hospital, Catholic University, Rome
  • Maria Anna Nicolazzi Department of Internal Medicine, Gemelli Hospital, Catholic University, Rome
  • Maria Teresa Congedo
  • Raffaele Landolfi Department of Internal Medicine, Gemelli Hospital, Catholic University, Rome

Abstract

Intralobar pulmonary sequestration is an uncommon congenital lung anomaly which consists of a mass of normal lung tissue not connected to the normal tracheobronchial tree and supplied by an anomalous systemic artery. Carbohydrate antigen 19-9 (CA 19-9) is widely accepted as a tumour marker for biliary, pancreatic and gastrointestinal cancer. However, CA 19-9 may also be increased in patients with benign disease. We describe the case of a 56-year-old woman with intralobar pulmonary sequestration who underwent unnecessary and extensive diagnostic abdominal examinations because of an increase in CA 19-9 serum levels.

Author Biography

Michele Impagnatiello, Department of Internal Medicine, Gemelli Hospital, Catholic University, Rome

 

Departement of internal medicine 

Doctor 

References

  • Savic B, Birtel FJ, Tholen W, Funke HD, Knoche R. Lung sequestration: report of seven cases and review of 540 published cases. Thorax 1979;34:96–101.

  • Ahn YH, Song MJ, Park SH. Intralobar pulmonary sequestration showing increased serum CA19-9. Tuberc Respir Dis 2012;72:507–510.

  • Armbruster C, Kriwanek S, Feichtinger H, Armbruster C. Intra-abdominal sequestration of the lung and elevated serum levels of CA 19-9: a diagnostic pitfall. HPB (Oxford) 2004;6:45–48.

  • Kristensen KL, Duus LA, Elle B. Endovascular treatment of an aneurysmal aberrant systemic artery supplying a pulmonary sequestrum. Cardiovasc Intervent Radiol 2015;38:1308–1311.

  • Gupta MK, Arciaga R, Bocci L, Tubbs R, Bukowski R, Deodhar SD. Measurement of a monoclonal-antibody- defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases: comparison with carcinoembryonic antigen. Cancer 1985;56:277–283.

  • Dong J, Cai Y, Chen R, Du S, Chen Y, Shi K. A case report and a short literature review of pulmonary sequestration showing elevated serum levels of carbohydrate antigen 19-9. J Nippon Med Sch 2015;82:211–215.

  • Montalto M, Santoro L, Vastola M, Curigliano V, Ricci R, Vecchio FM, et al. Normalisation of high CA 19-9 values in autoimmune hepatitis after steroidal treatment. Int J Immunopathol Pharmacol 2005;18:603–607.
  • Published: 2017-05-26

    Issue: Vol 4 No 4 (view)

    Section: Articles

    How to cite:
    Montalto, M., Impagnatiello, M., Nicolazzi, M. A., Congedo, M. T., & Landolfi, R. (2017). Intralobar Pulmonary Sequestration and Increased Serum CA 19-9. European Journal of Case Reports in Internal Medicine, 4(4). https://doi.org/https://doi.org/10.12890/2017_000583